Clinical Trial Update: Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 neoadjuvant trial evaluating hydroxychloroquine, palbociclib, and letrozole in estrogen receptor–positive, HER2-negative breast cancer; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)
• IBRANCE (PALBOCICLIB)
• Plaquenil (hydroxychloroquine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-02-17